Bortezomib Enhances Antigen-Specific Cytotoxic T Cell Responses Against Immune-Resistant Cancer Cells Generated by STAT3-ablated Dendritic Cells

Pharmacological Research - United States
doi 10.1016/j.phrs.2013.02.001
Full Text
Abstract

Available in full text

Categories
Pharmacology
Date
Authors
Publisher

Elsevier BV